A new study suggests that medicines used to treat osteoporosis might help relieve pain in people with complex regional pain syndrome (CRPS), but only for a short time—and not without risks.
The study, which is the largest of its kind so far, was published in the Annals of Internal Medicine.
CRPS is a serious and often disabling condition that causes long-lasting pain, usually in an arm or leg after an injury or surgery.
It can severely affect a person’s ability to move and live normally. Unfortunately, there are very few effective treatments for CRPS, and many people continue to live with pain and reduced quality of life.
To better understand whether osteoporosis drugs known as bisphosphonates could help, researchers looked at 11 clinical trials involving 754 adults with CRPS. The trials tested five types of bisphosphonates, given either as pills or through an intravenous (IV) drip.
The researchers found that bisphosphonates may reduce pain in the short term—about one to three months after treatment begins. However, they didn’t find strong evidence that these drugs help in the medium or long term. There were also no clear results about their effects right after treatment, and the long-term benefits remain uncertain.
The analysis showed that people taking bisphosphonates were more likely to experience side effects, including joint and muscle pain. While serious problems were rare, the risk of these milder side effects was higher in the treatment groups. The results also varied a lot between studies, making it difficult to draw firm conclusions.
One interesting finding was that people who had more signs of bone metabolism changes—thought to be one possible cause of CRPS in its early stages—might benefit more from bisphosphonate treatment. However, this idea needs more research to be confirmed.
In the end, the authors say that while bisphosphonates might offer some short-term pain relief for CRPS, doctors and patients need to be cautious. Any potential benefits should be weighed against the risk of side effects and the lack of evidence for lasting results.
More research is needed to figure out who is most likely to benefit from these drugs, and how best to use them—such as the right dose and length of treatment.
This study adds important new information to the limited pool of treatment options for CRPS. It gives hope for short-term relief but also highlights the need for more studies to better guide long-term care.
If you care about pain, please read studies about how to manage your back pain, and Krill oil could improve muscle health in older people.
For more health information, please see recent studies about how to live pain-free with arthritis, and results showing common native American plant may help reduce diarrhea and pain.
Copyright © 2025 Knowridge Science Report. All rights reserved.
